Market

Stay updated with the latest fintech market trends, insights, and analysis. Explore breaking news, market movements, and expert opinions to make informed decisions in the ever-evolving financial technology landscape

Latest Posts

Global Stocks Could Outperform US Equities in 2025

Wall Street's outlook for 2025 shifts away from US exceptionalism, favoring global stocks, gold, and European equities.

Nvidia Bulls Defend Ahead of Earnings on AI Cost Concerns

Nvidia (NVDA) rallies ahead of earnings, despite concerns over DeepSeek's AI cost challenge and Blackwell chip delays. Analysts remain cautiously optimistic, citing long-term growth opportunities in accelerated computing and generative AI.

Nikola Files for Bankruptcy as Electric-Vehicle Dream Stalls

Electric-vehicle maker Nikola Corp. (NKLA) files for Chapter 11 bankruptcy protection following a turbulent few years marked by fraud allegations, cash flow issues, and executive turnover.

Cinemark posts narrower Q4 net income as revenue rises

Cinemark Holdings Inc. (CNK) reported fourth-quarter profit of $51.3 million, missing Wall Street expectations. Revenue of $814.3 million topped forecasts.

New Weight-Loss Drugs Aim to Preserve Muscle, Expand Benefits

New weight-loss treatments aim to preserve muscle, potentially leading to additional health benefits beyond weight loss. The drugs target proteins linked to muscle growth and preservation, complementing existing GLP-1 therapies. Approval by the FDA may hinge on demonstrating benefits such as reduced side effects, improved heart health, and functional outcomes like increased stair-climbing ability.

New Weight-Loss Treatments Aim to Preserve or Grow Muscle

Current weight-loss methods often lead to muscle loss, increasing the risk of falls and reducing strength. Several companies are developing new treatments that aim to preserve or grow muscle mass while promoting weight loss, including Eli Lilly, Regeneron, Scholar Rock, Roche, Biohaven, Keros Pharma, Elevai Biosciences, Veru, 35 Pharma, Arrowhead Pharmaceuticals, and Six Peaks/AstraZeneca.

BOE Rate-Cut Bets Trimmed as Inflation Jump Spurs Hawkish Pivot

Traders trim bets on further UK interest rate cuts after surprise inflation jump

ECB's Schnabel Hints at Policy Pause as Rate Cuts Near End

ECB Policymaker Schnabel Signals Halt to Rate Cuts as Inflation Risks Rise

US Stocks Mixed as Fed Policy and Ukraine Talks in Focus

US stocks traded mixed on Tuesday following a holiday-shortened week, with the Federal Reserve and President Donald Trump's potential policy moves being closely watched.

Intel Stock Jumps on Rumored Interest From Broadcom, TSMC

Intel (INTC) stock surges 16% on potential acquisition talks with Broadcom and TSMC, driven by US government support for domestic chipmaking.